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 ABSTRACT. The first lab-on-chip system for picoliter droplet generation and RNA isolation, 
followed by reverse transcription, and PCR amplification with real-time fluorescence detection 
in the trapped droplets has been developed. The system utilized a shearing T-junction in a fused 
silica device to generate a stream of monodisperse picoliter-scale droplets that were isolated 
from the microfluidic channel walls and each other by the oil phase carrier.  An off-chip valving 
system stopped the droplets on-chip, allowing thermal cycling for reverse transcription and 
subsequent PCR amplification without droplet motion.  This combination of the established real-
time reverse transcription-PCR assay with digital microfluidics is ideal for isolating single-copy 
RNA and virions from a complex environment, and will be useful in viral discovery and gene-
profiling applications. 
Keywords:  on-chip PCR, picoliter PCR, microdroplet, digital microfluidics, real-time PCR, 
digital PCR, w/o emulsion, qPCR, reverse transcription PCR, RT-PCR, gene profiling 
Introduction 
The accurate detection and identification of low levels of pathogens in complex samples is 
critical in a number of applications such as clinical medicine, environmental monitoring, and 
biodefense.  Developments in highly sensitive nucleic acid amplification techniques, as well as 
the explosion in the available genome sequences due to comprehensive sequencing efforts, have 
made PCR analysis the method of choice for low level pathogen detection.  Taqman-based real-
time quantitative PCR using dual-labeled fluorogenic probes to provide accurate quantitation of 
gene copies1 is now used extensively for rapid characterization of pathogens since it requires no 
post amplification manipulation or integration with electrophoresis systems, hybridization arrays, 
or mass spectrometry2.  Also, with the addition of a reverse transcription step, PCR assays can be 
modified to enable detection of low levels of RNA.  This capability, reverse transcription PCR 
 
 (RT-PCR), is critical in the detection of emerging viral threats, many of which are caused by 
retroviruses, organisms having RNA genomes.    
Recently, development of microfluidic techniques has led to advances in performing PCR assays 
including reduction of sample and reagent consumption, and increases in speed, sensitivity and 
dynamic range.  Emulsion techniques are a promising new variation of microfluidics where 
aqueous droplets act as tiny, isolated chemical reactors suspended in a hydrophobic medium.   
This approach offers the possibility of greatly simplified microfluidic fabrication as well as 
increases in sample throughput.  Emulsion PCR has been used to detect single genome copies 
and has been integral in new methods of high throughput genome sequencing3.  Because of the 
segregation of DNA copies into individual compartments, amplification bias, where short or 
higher copy number sequences are preferentially amplified, is reduced.  This advantage has been 
realized in medical diagnostics where low levels of mutant oncogenes4 and a series of Y 
chromosome microdeletions5 have been found that were not detectable using traditional bulk 
amplification methods.  Such a capability is critical in detection of important, but low copy 
number pathogens whose presence could be masked by high concentration, interfering 
background species in complex environmental or clinical samples. 
 
A complete analysis of samples containing pathogens requires the ability to detect both DNA and 
RNA based organisms.  While extensive work has been done on microfluidic PCR based assays, 
less has been done on RT PCR systems.  In microfabricated compartments, RT-PCR in 450 pL 
reactors has been demonstrated down to an estimated level of 34 RNA copies6.  Nanoliter 
volume RT-PCR has been integrated to on-chip capillary electrophoresis to detect 11 RNA 
copies in 45 minutes7. RT-PCR has also been performed in batch-generated emulsions at the 
single copy level8. However, bulk emulsion methods typically use end-point amplification 
 
 detection after breaking the emulsion and recombining all the amplified nucleic acids8.  To 
perform rapid real-time detection the droplets must be focused into a channel so background 
fluorescence from droplets outside the focal plane does not affect the fluorescence intensity 
measurement, allowing optical interrogation of individual reactors. Additionally, generation of 
droplets in a microfluidic channel offers a level of control over size and quantity of reactants in 
droplets not achievable with bulk emulsion methods. 
Previously, we demonstrated detection of single copies of the DNA virus vaccinia using 
microdroplet real time PCR9.  Given that a number of recently emerging threats are retroviruses, 
we are interested in expanding our capabilities to include detection of low levels of RNA viruses 
as well. Here we report the first on-chip digital microfluidic real-time RT-PCR instrument for 
generating monodisperse isolated picoliter reactors and demonstrate its use in thermal cycling for 
reverse transcription and PCR, and real time detection of single genome copies.  
 
Experimental section 
Droplet Generation chip design A microfluidic chip with channels coated to create hydrophobic 
surfaces was used to create droplets and perform PCR amplification.  Monodisperse droplets 
with tunable volumes are generated at a T-junction where a flowing oil stream shears off slugs of 
an aqueous stream into a main flow channel.  The nascent aqueous boluses relax into a spherical 
shape provided the channel cross section is sufficiently large to prevent wall interactions.  
Droplet size is adjusted by varying channel geometry, flow rate, and dispersed phase viscosity10, 
11.  An effective T-junction width for channels of rectangular cross section was determined 
previously9 and has been applied to the  circular cross section used in this study.  The width of 
the channels in the current device increases from 60 µm at the T-junction to 150 µm downstream 
to allow more droplets to be measured simultaneously in the fixed field of view.  Two inlet and 
 
 one outlet fluidic connections were made to the edge of the chip using either epoxied fused silica 
capillaries or a gasket assembly connector.  To prevent cross-contamination between 
experiments, the fluid lines and channels were rinsed with a 10% (0.6% m/v, 10 μL) solution of 
household bleach while the chip was heated to 90°C, followed by deionized water (120 μL) prior 
to each run. 
 
Device fabrication Microfluidic chips were fabricated by isotropically etching 30 µm deep 
features into two 1 mm-thick fused silica wafers.  The two etched wafers, which are mirror 
images of each other, were then aligned and thermally bonded, generating channels which are 
elliptical in cross section.  To enhance detection of fluorescence from the droplets in the channels, 
the microfluidic devices were coated on one side with a 30 nm adhesion layer of chromium and a 
300 nm layer of gold by an e-beam thermal evaporator, creating a mirror plane at the top surface 
of the chip.  Prior to use, all chip-based devices and fused silica capillary tubing were rendered 
hydrophobic through coating with vapor-deposited 1H,1H,2H,2Hperfluorodecyltrichlorosilane 
(FDTS), performed by Applied Microstructures, Inc.   
 
System Architecture In addition to the device redesign and the chip substrate change, the picoliter 
droplet real-time PCR instrument  previously described9 was extensively modified for RT-PCR 
as follows.  Flow for both the aqueous and oil streams was controlled individually by a 
NanoFlow Metering System (PN: 950-00008, Eksigent Technologies).  A mixture of viral MS2 
sample and RT-PCR master mix was delivered to the aqueous channel of the chip and PCR 
mineral oil (M8662, Sigma-Aldrich) to the oil channel. Stabilizing additives were not required, 
which simplified translation of the RT-PCR protocol to the picoliter regime.  Two Rheodyne 
 
 MHP7900-500-1 six-port valves with attached holding coils for the oil and aqueous phases were 
coupled to a Rheodyne MHP7980-500-1 six-port flow synchronization valve to facilitate droplet 
trapping on-chip.  The Peltier Thermo Electric Cooler (TEC) used previously was replaced with 
the system described below in Thermal Cycling.  Finally, an automated 2-axis microscope stage 
was implemented as described in Fluorescence detection below.  See Figure 1a) & b). 
 
Thermal cycling The contact thermal cycling assembly was built using an 18.9 ohm flexible 
Kapton resistive heating element in contact with an aluminum heat spreading strip on the 
opposite side of which a thermally conductive silicone pad was mounted to provide conformal 
contact with the device.  To increase the cooling surface area and maximize the cooling rate, 
0.001 in-thick copper foil was mounted to the aluminum heat spreading strip.  House-generated 
100 psi compressed air was directed to the copper foil for device cooling.  The temperature was 
controlled through a Watlow Series 96 temperature controller connected to a thermocouple 
attached to the aluminum heat spreading strip.  The programmed RT-PCR profile was 15 
minutes at 55°C for the virion capsid lysis and reverse transcription step, followed by 180 s at 
95°C, then 40 cycles of 94°C for 20 s, 55°C for 15 s, and 69°C for 10 s.  The thermal profile was 
calibrated using a 0.003 in Type-K bare-wire thermocouple embedded into the microfluidic 
device, in plane with the microfluidic channel.  The heating and cooling rates were ~5°C/s and 
2°C/s, respectively.   
 
PCR Reagents Per 25 μL, the RT-PCR mastermix contained 1x Superscript III reaction buffer, 4 
μL of Superscript III Reverse Transcriptase / Platinum Taq Polymerase mix (Invitrogen), 0.2 μM 
forward primer 5´-GGAGAGACAGGGCACTGCTA-3´, 0.2 μM reverse primer 5´-
 
 TTGGCCATACGGATTGTACC-3´, 0.2 μM 5´FAM-CCCAAATCTCAGCCATGCATCGAG-
3´BHQ1 probe (Biosearch Technologies), 0.04 μg/μL BSA, and MS2.  The MS2 virions were 
cultured at Lawrence Livermore National Laboratory using standard procedures.  Virion 
concentration was quantified by plaque assays to determine the initial stock titer of active virus 
particles in plaque forming units per mL, (pfu/mL).  The stock template solution was used to 
generate a dilution series of 1:1, 10, 100, 500, and 1000 for the on chip experiments.   
Fluorescence detection Fluorescence was monitored using a Nikon TE2000-U microscope fitted 
with a 41001 FAM Chroma filter set, a 4× Nikon objective and a Nikon Intensilight DC arc lamp.  
Fluorescence images were captured at up to three imaging locations with a CoolSnap HQ2 CCD 
(1392 x 1040 pixels) with a 100 ms acquisition time to avoid observable fluorophore 
photobleaching effects.  Bright field images were acquired with a MotionPro HS-4 CMOS 
camera (Redlake) at 5,000 frames per second (512 x 512 pixels).  The fluorescence microscope 
imaged droplets in a 750 x 1,250 μm section of the chip during the annealing phase of each cycle 
for real-time detection. Scanning between the imaging locations was performed by an ASI 
motion controller and XY stage mounted on the Nikon microscope and controlled in LabVIEW. 
 
Data Analysis Brightfield images were analyzed using the watershed edge detection method12 to 
identify and locate the individual droplets.  Average pixel intensity for each droplet was tracked 
through 40 cycles of PCR.  The droplet real-time fluorescence curves were then processed using 
an algorithm adopted from a commercial instrument (SmartCycler Operator Manual D0190 Rev. 
D, Cepheid, Sunnyvale, CA) to subtract background fluorescence and determine cycle threshold, 
Ct, using a threshold value of 0.2 intensity units.   
 
Results and Discussion 
 
 The device successfully generated and trapped highly monodisperse droplets on-chip for use as 
captive RT-PCR reactors.  Adequate droplet spacing was used to ensure that flow stoppage 
caused no observable coalescence.  Once stopped, the droplets remained stationary throughout 
the duration of PCR thermal cycling.  A brightfield image of a typical trapped droplet field is 
shown in Figure 1a).  
Sixteen separate experiments were performed using sample concentrations ranging from 0.05 
to 47 pfu/droplet.  On-chip RT-PCR results from one of the three imaging locations for a typical 
run is summarized in Figure 2.  For this particular run, droplets had an average diameter of 51 
µm and a computed average droplet volume of 70 pL. Fluorescence images were recorded at 
each thermal cycle and images from two characteristic cycles, 0 and 30, are shown in Figure 2b)-
2c).  As expected, fluorescence of the probe increases as amplification proceeds.  Figure 2d) 
shows the droplet intensity real-time fluorescence curves generated from the fluorescence images 
for the same droplet field.  The Ct, where the fluorescence intensity crosses the critical threshold, 
averaged 23.6 with a standard deviation of 2.1 for the run, as determined by the data analysis 
algorithm.  The real-time fluorescence intensity curves for each droplet in the study exhibited the 
typical exponential, linear, and plateau phases of PCR, similar to those observed in bench-top 
microliter-scale reactions.   
Analysis of fluorescence intensities of all droplets from all sixteen runs (1,241 total droplets) 
led to the cycle threshold versus log of copy number in pfu/droplet as shown in Figure 3.  
Repeatable amplification was observed at all positive starting concentrations, with the expected 
linear relationship between cycle threshold and log of starting copy number per droplet for 
starting concentrations at or above single copy levels.  The trend in increasing cycle threshold   
with decreasing pfu/droplet plateaus at concentrations where copy number per droplet falls 
 
 significantly below one (red points in Figure 3).  This behavior is expected at dilutions where 
individual droplets either contain one or no RNA genomes, so lowering the concentration further 
does not lower the starting copy number for individual droplets, but will lower the overall 
number of droplets containing genomes.  
Below approximately 1 pfu per droplet, the percentage of successfully amplified droplets falls 
appreciably, as seen in Figure 4, which plots the percent of droplets showing amplification 
versus the calculated pfu copy number per droplet.  This decrease in percent amplification is 
consistent with the plateau of the Ct seen in Figure 3, indicating digital PCR.  The profile 
expected from Poisson statistics is shown as a blue line for comparison.  The data exhibit the 
same general trend as the Poisson-predicted curve, but the observed droplet amplification 
percentages are higher than predicted by Poisson statistics.  Such a shift in the Poisson curve 
from the data would be expected in the case where the plaque assay measurement was an under 
representation of the actual number of viral genomes present.  This is consistent with previous 
studies, which have reported that viral titers determined by quantitative PCR tend to be at least 
10 times higher than those measured by plaque assays13, 14. 
The agreement between observed and Poisson-predicted droplet amplification for the total 
starting copy concentration across all dilutions demonstrates the suitability of droplets for 
sensitive quantitative RT-PCR.  Future directions of this research will focus on optimizing the 
assay for the picoliter scale emulsion, demonstrating this method on different viral genomes, and  
adapting to continuous flow thermal cycling15 to increase droplet throughput. 
 
Conclusions 
 
 We have demonstrated on-chip RNA isolation in picoliter droplets, reverse transcription within 
the individual droplets, and subsequent real-time PCR with fluorescence detection of 
amplification in each interrogated droplet.  The system employed a method of sample 
partitioning into monodisperse picoliter droplets emulsified in oil to generate isolated chemical 
reactors for high sensitivity nucleic acid detection.  The method required approximately twenty-
three cycles for single-copy real-time reverse transcription from RNA, amplification, and 
detection on-chip using Taqman-based probes.  The results show the method is well-suited to 
quantitative PCR applications, given the observability of Poisson statistics in the picodroplet-
discretized sample. Applying digital microfluidics to real-time RT-PCR combines the advantages 
of on-chip processing of picoliter reactors with single-copy detection. 
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Figure 1.  On-chip RT-PCR device and schematic. Panel a) shows the fused silica device with an 
inset of monodisperse ~70 pL droplets trapped and ready for subsequent PCR.  Panel b) is a 
schematic of the instrument. 
 
 
  
 
 
 
 
 
 
 
Figure 2.  Representative on-chip RT-PCR results from one of the three imaging locations. Panel 
a) shows the brightfield image after thermal cycling.  Droplets have a volume of ~70 pL Panels 
b) & c) show the fluorescence intensity at cycles 0 and 30 respectively.  Panel d) is a plot of 
fluorescence intensity versus cycle number for all the droplets in the field of view- with a 5-point 
moving average applied to the intensities to smooth the real-time curve.  Note that 23 of the 25 
droplets in panel a) supported amplification. 
 
 
  
Figure 3.  Cycle Threshold versus log(plaque forming units per droplet) for all sixteen runs.  The 
total number of droplets analyzed is 1241.  Error bars correspond to +/- standard deviation.  The 
plateau at the lower concentrations (points in red) signifies the single-copy Ct limit has been 
reached.  The R2 value of ~0.92 is for the range of -0.55 to 1.70. 
 
 
 
 
  
Figure 4.  Percentage of droplets amplified versus starting copy number per droplet (symbols) 
against that predicted by Poisson statistics (blue curve).   
 
 




